Lupus nephritis (LN) is a serious complication for many patients who develop systemic lupus erythematosus, which primarily afflicts women. Our studies to identify biomarkers and the pathogenic mechanisms underlying LN will provide a better understanding of disease progression and sex bias, and lead to identification of additional potential therapeutic targets. The glycosphingolipid lactosylceramide (LacCer) and N-linked glycosylated proteins (N-glycans) were measured in urine and serum collected from LN and healthy control (HC) subjects (10 females and 10 males in each group). The sera from the LN and HC subjects were used to stimulate cytokine secretion and intracellular Ca2+ flux in female- and male-derived primary human renal mesangial c...
Background: Progression and long-term renal outcome of lupus nephritis (LN) in male patients is a co...
There are controversial results about the role of serum leptin and adiponectin levels as biomarkers ...
Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with var...
Gender may produce different characteristics in the manifestation of systemic lupus erythematosus (S...
OBJECTIVE: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in p...
BackgroundLupus nephritis (LN) is a crucial complication of systemic lupus erythematosus (SLE) and h...
OBJECTIVE: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in p...
Lupus nephritis is one of the most severe manifestations of systemic lupus erythematous. Renal invol...
Objective: Glycoprotein acetylation (GlycA) is a novel biomarker for chronic inflammation, associate...
Objective Changes in protein glycosylation are a hallmark of immune-mediated diseases. Glycans are m...
The development of nephritis increases the risk of morbidity and mortality in systemic lupus erythem...
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), ...
BackgroundManagement of lupus nephritis (LN) would be greatly aided by the discovery of biomarkers t...
WOS: 000178303700004PubMed ID: 12189454Renal involvement in systemic lupus erythematosus (SLE) affec...
In Systemic Lupus Erythematosus (SLE) patients, renal involvement is the most important complication...
Background: Progression and long-term renal outcome of lupus nephritis (LN) in male patients is a co...
There are controversial results about the role of serum leptin and adiponectin levels as biomarkers ...
Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with var...
Gender may produce different characteristics in the manifestation of systemic lupus erythematosus (S...
OBJECTIVE: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in p...
BackgroundLupus nephritis (LN) is a crucial complication of systemic lupus erythematosus (SLE) and h...
OBJECTIVE: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in p...
Lupus nephritis is one of the most severe manifestations of systemic lupus erythematous. Renal invol...
Objective: Glycoprotein acetylation (GlycA) is a novel biomarker for chronic inflammation, associate...
Objective Changes in protein glycosylation are a hallmark of immune-mediated diseases. Glycans are m...
The development of nephritis increases the risk of morbidity and mortality in systemic lupus erythem...
The most common complication in patients with systemic lupus erythematosus is lupus nephritis (LN), ...
BackgroundManagement of lupus nephritis (LN) would be greatly aided by the discovery of biomarkers t...
WOS: 000178303700004PubMed ID: 12189454Renal involvement in systemic lupus erythematosus (SLE) affec...
In Systemic Lupus Erythematosus (SLE) patients, renal involvement is the most important complication...
Background: Progression and long-term renal outcome of lupus nephritis (LN) in male patients is a co...
There are controversial results about the role of serum leptin and adiponectin levels as biomarkers ...
Systemic lupus erythematosus (SLE) is a chronic, relapsing, polysystemic autoimmune disease with var...